About Miroculus
Miroculus is a company based in San Francisco (United States) founded in 2014 by Fay Christodoulou was acquired by Integra Biosciences in March 2023. Miroculus has raised $48.42 million across 4 funding rounds from investors including Cota Capital, S32 and Nazca. Miroculus has completed 1 acquisition, including Kapplex. Miroculus operates in a competitive market with competitors including Biological Dynamics, Geneoscopy, Mirvie, OncoCyte and Epic Sciences, among others.
- Headquarter San Francisco, United States
- Founders Fay Christodoulou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.42 M (USD)
in 4 rounds
-
Latest Funding Round
$20.22 M (USD), Series B
Feb 25, 2021
-
Investors
Cota Capital
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Integra Biosciences
(Mar 16, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Miroculus
Unlock access to complete
Unlock access to complete
Funding Insights of Miroculus
Miroculus has successfully raised a total of $48.42M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $20.22 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Miroculus
Miroculus has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Cota Capital, S32 and Nazca.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic venture capital investments are focused on US sectors.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in innovative technology startups.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on empowering Latin American founders.
|
Locked | Locked | Locked |
Investor details for Miroculus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Miroculus
Miroculus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kapplex.
Investment portfolio details for Miroculus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Point-of-care diagnostic platforms are developed for healthcare applications.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Miroculus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Miroculus
Detailed financials for Miroculus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Miroculus Comparisons
Peer comparison for Miroculus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Miroculus
Miroculus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Geneoscopy, Mirvie, OncoCyte and Epic Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
Non-invasive biomarker tests for colorectal cancer are developed.
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Non-invasive tests for detecting circulating tumor cells are provided.
|
Detailed competitors of Miroculus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Miroculus
Complete news archive for Miroculus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miroculus
Miroculus was founded in 2014.
Miroculus is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Miroculus is a funded company, having raised a total of $48.42M across 4 funding rounds to date.
Miroculus was founded in 2014 in San Francisco, United States, within the biotechnology sector. A MicroRNA profiling platform is developed to identify genes in biological samples. Operations center on the Miro Canvas product, which employs microfluidic technology to automate experimental workflows via cartridges. Minimally invasive molecular testing is facilitated through these processes, supporting diagnostic applications in research and healthcare.
Miroculus's top competitors include Geneoscopy, Mirvie and OncoCyte.
Miroculus has made 1 acquisition, including Kapplex.
Miroculus has 4 investors. Key investors include Cota Capital, S32, Nazca, and Integra Biosciences.